BIOSAFETY AND BI
Force
OSECURITY
1. A non-government and non-profit
association that works to serve the
emergent concerns of biological
risk management in various field
such as in health, agriculture and
technology sectors
2. A regional professional society for
biosafety founded in 1984 that
promotes biosafety as a scientific
discipline and provides guidance
on the regulatory regime in North
America
3. A non-profit org that is founded in
June 1996 that aims to provide a
forum for discussions and debates
to those who are working in the
field of biosafety. It focuses on
encouraging and communicating
as well as emerging legislations
and standards
4. Founded in 2005 that acts as a
professional society for biosafety
in the Asia-Pacific region. The
members are required to directly
contribute to the development of
the best biosafety practices
5. Countries involve in A-PBA
6. A multidisciplinary team with
members coming from the health
and education sectors as well
individuals from the executive,
legislative, and judicial branches,
and also those working groups of
the National Laboratory Biosafety
and Biosecurity Action Plan Task
7. PhBBA established as per DPO No.
2006-2500 dated___
8. Issued a common understanding
of biosafety derived from the
practical guidance on techniques
to be used in the laboratories
9. Laboratory Biosafety Manual
defines it as the protection,
control, and accountability for
valuable biological materials
within laboratories, in order to
prevent their unauthorized access,
loss, theft, misuse, diversion or
international release
10. Containment principles,
technologies, and practices that
are implemented to prevent
unintentional exposure to
pathogens, toxins or their
accidental release
11. In 1996, he created the biohazard
symbol used in labeling biological
materials carrying significant
health risks
12. Focuses on laboratory procedures
and practices necessary to prevent
exposure to and acquisition of
infections
13. Maintenance of secure procedures
and practices in handling
biological materials and sensitive
info
14. Risk group that includes
microorganism that are unlikely to
cause human or animal disease.
And low community and individual
risk
15. Risk group that includes
microorganism that produce life-
 threatening diseases to humans or
animals and represent a significant
risk and may be readily
transmissible: high individual and
community risk
16. Risk group that includes
microorganism that are unlikely to
be a significant risk, laboratory
exposure however may cause
infection, but effective treatment
and preventive measures are
available: moderate individual risk
and limited community risk
17. Risk group that includes
microorganism that cause serious
diseases and may present a
significant risk to lab workers:
high individual risk and limited to
moderate community risk
18. The one who categorized lab into 4
biosafety levels
19. Biosafety level suitable for work
involving viable microorganisms
that are known to not cause
disease (school level)
20. BS level that puts emphasis in the
protection of individuals from
infectious aerosol exposure
21. BS level that is required for work
with dangerous and exotic agents
that pose high individual risk of
life-threatening diseases; requires
a specific building or isolated zone
22. BS level that deals with indigenous
moderate-risk agents present in
the community and usually blood-
borne diseases
IDENTIFY THE BSLEVEL
23. Coxiella
24. Hepatitis B
25. Toxoplasma species
26. Bacillus subtilis
27. Salmonellae
28. Marburg/ Crimean-Congo
hemorrhagic fever
29. Mycobacterium tuberculosis
30. Naegleria gruberi
31. St. louis encephalitis virus
32. HIV
33. H1N1
34. MersCOV
35. Ebola virus
36. SARS
37. What cabinet is needed for BSL-4?
38. Risk associated to biological toxins
or infectious agents; the source of
risk may be unintentional
exposure to unauthorized access,
accidental release or loss, theft,
misuse, diversion, or intentional
unauthorized release of
biohazards
39. Integration of biosafety and
biosecurity to manage risks when
working with biological toxins and
infectious agents
40. An org who defines biorisk
management as a system or
process to control safety and
security risk associated with the
handling or storage and disposal
of biological agents and toxins in
lab and facilities
41. BRM is divided into three
components
42. This model requires that control
measures be based on a robust risk
assessment, evaluation of
effectiveness and sustainability of
control measures
43. Includes the identification of
hazards and characterization of
 risks that are possibly present in
the lab
44. Defined as the possibility that
something bad or unpleasant
(such as an injury or loss) will
happen
45. Anything in the environment that
has the potential to cause harm
46. Step in risk assessment that lets
the team identify the hazards and
risks of the biological agents to be
handled
47. To characterize the overall
biosafety risks, the risk
assessment team needs to
compare the likelihood and the
consequences of infection
48. This process of evaluating the
biorisk arising from a biohazard
takes into account the adequacy of
any existing controls, and deciding
whether or not the biorisk is
acceptable
49. Defining the risks must include a
review of how individuals inside
and outside the lab may be
exposed to the hazards through
droplets, inhalation, ingestion, etc.
50. Second fundamental component
of the biorisk management
51. The most difficult and effective
control measure that involves the
total decision not to work with a
specific biological agent or even
not doing the intended work;
highest degree of risk reduction
52. The least effective control
measure; devices that are worn as
a protection
53. Control measure that includes
physical changes in work stations,
equipment, production facilities,
or any other relevant aspect of the
work environment that can reduce
or prevent exposure to hazards
54. The second control measure that is
the replacement of the procedures
or biological agent with a similar
entity in order to reduce the risks
55. Control measure that refers to the
policies, standards, and guidelines
used to control risks
56. A spore-forming bacillus that is
resistant to damage and
transmitted through inhalation
57. An air-borne life-threatening
disease, Tularemia, is from what
bacteria?
58. “Not one of the mitigation control
or measures is completely
effective at controlling/reducing
all risks; but relies on the
combination of all the different
measures and the proper
utilization of each”
59. Last pillar of the biorisk
management model that involves
a systematic process intended to
achieve organizational objectives
and goals
60. A reevaluation of the overall
mitigation strategy
61. Essential component of health
institutions; place where
specimens collected from
individuals are produces, analyzed,
preserved, and properly disposed
62. __ percent of all decisions
performed by med doctors are
based on lab test results
63. Classification of clinical lab based
on function that focuses on the
 area of histopathology,
immunohistopathology, cytology,
autopsy, forensic pathology;
microscopic examination of tissues
and organs
64. Classification of clinical lab based
on function that focuses on the
area of clinical chem,
immunohematology, blood
banking, med microbiology,
immunology and serology,
hematology, parasitology, clinical
microscopy, toxicology,
therapeutic drug monitoring and
endocrinology; testing of blood
and other body fluids
65. According to institutional
characteristics; operates within
the premises or part of an
institution such as hospital, school
etc.
66. According to institutional
characteristics; not part of an
established institution
67. According to ownership; owned,
established and operated by
individual, corporation, institution,
association, or organization
68. According to ownership; owned
wholly or partially, by national or
local gov. units
69. Example of government-owned
70. Example of privately-owned
71. According to service capability;
perform basic routine analysis
72. According to service capability;
licensed to perform all the lab test
73. According to service capability;
licensed to perform lab tests being
done by the primary category
clinical lab along with clinical lab
74. Square meters in primary
75. Square meters in tertiary
76. Square meters in secondary
77. According to service capability;
hospital designated by the DOH to
provide special diagnostic
functions and services for certain
diseases
IDENTIFY THE DIFFERENT AREAS
FOR VARIOUS TESTS
78. Blood donation program
79. Antibody screening and
identification
80. NS1-Ag for dengue
81. Differential staining techniques
82. Bone marrow studies
83. Clinical enzymology
84. Rapid plasma reagin
85. Preparation for blood components
86. Culture and identification of bac.
and fungi
87. Therapeutic drug monitoring
88. Special staining for abnormal
blood cells
89. Treponema pallidum particle
agglutination test
90. Anti-microbial susceptibility
testing
91. Red cell orphology
92. An act regulating the operation
and maintenance od clinical lab
and requiring the registration of
the same with the department of
health, providing penalty for the
violation
93. Clinical Laboratory Law
94. License to practice medtech
95. Rules and regulation governing
the establishment, operation and
maintenance of clinical
laboratories in the Philippines
96. Area in the lab intended for testing
blood and other body fluids to
quantify essential soluble
chemicals including waste
products useful for the diagnosis
of disease
97. Area in the lab that includes
microscopic visualization of
microorganisms after staining,
isolation, and identification of
bacteria and fungi using varied
culture media
98. Section in the lab that deals with
the enumeration of cells in the
blood and other body fluids
99. Cellular components of blood
100. Area in the lab that includes
examination of urine and routine
fecalysis
101. Two main activities performed in
the blood
bank/immunohematology
102. Area in the lab that screens
all antibodies and identification as
well as the blood components
used for transfusion
103. Analyses of serum
antibodies in certain infectious
agents
104. Under the anatomic
pathology that includes tissue
processing, cutting into sections,
staining, and preparation for
microscopic examination
105. Specialized section of the
lab that combines anatomical,
clinical, and biochemical
techniques where antibodies
bounded to enzymes and
fluorescent dyes are used to
detect presence of antigens in
tissue
106. Area in the lab where it
detects any pathologic
conditions/disease processes and
currently uses the polymerase
chain reaction
107. Phase where errors in the
lab mostly occurs
108. Phase where it happens the
actual testing
109. Phase where data is
transmitted/interpreted, and the
release of the results
110. Quality Assurance that includes
day-to-day activities that are
undertaken in order to control
factors or variable that may affect
test results
111. Quality Assurance that is a system
for checking performance among
clinical lab and is facilitated by
designated external agencies
IDENTIFY THE NRL-EQAS FOR THE
FOLLOWING
112. Drugs of abuse
(methamphetamine and
cannabinoids)
113. Clinical chem (glucose, crea, TP,
albumin, NUN, UA. CHOL, Na, K, Cl)
114. Infectious HBsAg, HIV, HCV
115. Hematology and Coagulation
116. Microbiology and Parasitology
117. It encompasses all activities
performed by lab personnel to
ensure reliability of test results